WO2013015634A3 - Pharmaceutical composition for treating atopic dermatitis - Google Patents

Pharmaceutical composition for treating atopic dermatitis Download PDF

Info

Publication number
WO2013015634A3
WO2013015634A3 PCT/KR2012/005974 KR2012005974W WO2013015634A3 WO 2013015634 A3 WO2013015634 A3 WO 2013015634A3 KR 2012005974 W KR2012005974 W KR 2012005974W WO 2013015634 A3 WO2013015634 A3 WO 2013015634A3
Authority
WO
WIPO (PCT)
Prior art keywords
atopic dermatitis
pharmaceutical composition
treating atopic
dermatitis patients
treating
Prior art date
Application number
PCT/KR2012/005974
Other languages
French (fr)
Other versions
WO2013015634A2 (en
Inventor
Sung Soo Jun
Soon Im Lee
Original Assignee
Hanall Biopharma Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hanall Biopharma Co., Ltd. filed Critical Hanall Biopharma Co., Ltd.
Priority to EP12818423.1A priority Critical patent/EP2736517A4/en
Publication of WO2013015634A2 publication Critical patent/WO2013015634A2/en
Publication of WO2013015634A3 publication Critical patent/WO2013015634A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7135—Compounds containing heavy metals
    • A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

A method of treating mild atopic dermatitis patients by locally administering an external composition containing adenosylcobalamin as an active ingredient is provided. The composition can effectively treat mild atopic dermatitis patients without side effects.
PCT/KR2012/005974 2011-07-26 2012-07-26 Pharmaceutical composition for treating atopic dermatitis WO2013015634A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP12818423.1A EP2736517A4 (en) 2011-07-26 2012-07-26 Pharmaceutical composition for treating atopic dermatitis

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR10-2011-0074032 2011-07-26
KR1020110074032A KR20130012709A (en) 2011-07-26 2011-07-26 Pharmaceutical composition for treating atopic dermatitis

Publications (2)

Publication Number Publication Date
WO2013015634A2 WO2013015634A2 (en) 2013-01-31
WO2013015634A3 true WO2013015634A3 (en) 2013-04-04

Family

ID=47601668

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2012/005974 WO2013015634A2 (en) 2011-07-26 2012-07-26 Pharmaceutical composition for treating atopic dermatitis

Country Status (3)

Country Link
EP (1) EP2736517A4 (en)
KR (1) KR20130012709A (en)
WO (1) WO2013015634A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL423135A1 (en) * 2017-10-11 2019-04-23 Axxon Spolka Z Ograniczona Odpowiedzialnoscia Liposome preparation that contains vitamin B12 as the active substance, pharmaceutical composition that contains it and method for producing the liposome preparation

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6255294B1 (en) * 1998-12-28 2001-07-03 Allergy Limited Cyanocobalamin (vitamin B12) treatment in allergic disease
US20050186293A1 (en) * 2002-04-15 2005-08-25 Tetsuo Santo Drinking tea for treating dermatitis
KR100658436B1 (en) * 2005-12-09 2006-12-27 한국화학연구원 Compositions for external application, containing adenosylcobalamin for improvement of skin diseases
US20070243132A1 (en) * 2005-12-22 2007-10-18 Apollo Life Sciences Limited Transdermal delivery of pharmaceutical agents

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6255294B1 (en) * 1998-12-28 2001-07-03 Allergy Limited Cyanocobalamin (vitamin B12) treatment in allergic disease
US20050186293A1 (en) * 2002-04-15 2005-08-25 Tetsuo Santo Drinking tea for treating dermatitis
KR100658436B1 (en) * 2005-12-09 2006-12-27 한국화학연구원 Compositions for external application, containing adenosylcobalamin for improvement of skin diseases
US20070243132A1 (en) * 2005-12-22 2007-10-18 Apollo Life Sciences Limited Transdermal delivery of pharmaceutical agents

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
JUNG, S. H. ET AL.: "Topical application of liposomal cobalamin hydrogel for atopic dermatitis therapy.", PHARMAZIE, vol. 66, no. ISS.6, June 2011 (2011-06-01), pages 430 - 435, XP055141011 *
See also references of EP2736517A4 *
STUCKER, M. ET AL.: "Topical vitamin B12-a new therapeutic approach in atopic dermatitis-evaluation of efficacy and tolerability in a randomized placebo- controlled multicentre clinical trial", BR. J. DERMATOL., vol. 150, no. ISS. 5, 2004, pages 977 - 983, XP007910269 *

Also Published As

Publication number Publication date
EP2736517A2 (en) 2014-06-04
KR20130012709A (en) 2013-02-05
WO2013015634A2 (en) 2013-01-31
EP2736517A4 (en) 2014-12-24

Similar Documents

Publication Publication Date Title
WO2013170068A3 (en) Nuclear transport modulators and uses thereof
EA201590053A1 (en) MODULATORS OF THE COMPLEMENT SYSTEM AND THEIR APPLICATION
WO2014002051A3 (en) Complement pathway modulators and uses thereof
WO2011127333A3 (en) Compounds for treating disease, for administering, and for pharmaceutical compositions
WO2013052699A3 (en) Novel quinoxaline inhibitors of pi3k
WO2013100567A8 (en) Phenyl carbamate compounds for use in alleviating or treating pain and neuropathic pain
WO2014002058A3 (en) Complement pathway modulators and uses thereof
WO2014009833A3 (en) Complement pathway modulators and uses thereof
SG10201914117QA (en) Treatment Of Myelosuppression
PH12014501967A1 (en) Benzodioxanes in combination with other actives for inhibiting leukotriene production
WO2012050831A3 (en) Combination treatment for dermatological conditions
CA2881554C (en) Methods for inhibiting fascin
EP2796450A4 (en) 6-aminopyridine-3-ol derivatives or pharmaceutically acceptable salts thereof, and pharmaceutical composition containing same as active ingredients for preventing or treating diseases caused by angiogenesis
PH12014502065A1 (en) Vesicular formulations
MX2014014814A (en) Pharmaceutical composition for treating inflammation and pain.
WO2012177075A3 (en) Composition containing antibiotics and lysophosphatidylcholine for boosting immunity or treatment of bacterial infections
EA201200319A1 (en) INTRODUCTION OF ACTIVATED CARBON IN THE RENDERING OF EMERGENCY ASSISTANCE IN THE CASE OF OVERDOSE OF DAGIGATRAN ETEXILATE
WO2013015634A3 (en) Pharmaceutical composition for treating atopic dermatitis
MX368640B (en) PHARMACEUTICAL COMPOSITION FOR TREATING INFLAMMATION and PAIN.
UA109944U (en) PHARMACEUTICAL COMPOSITION TO REDUCE THE N-OXIDE OF TRIMETHYLAMINE LEVEL
MX2014003867A (en) Treatment of rhinitis.
GEP201706614B (en) Compounds, pharmaceutical compositions and a method for the prophylaxis and treatment of the adhesion process
MX358470B (en) Administration of eritoran or pharmaceutically acceptable salts thereof to treat orthomyxovirus infections.
MY166463A (en) Positive allosteric modulators of nicotinic acetylcholine receptor
PH12015501211A1 (en) Use of pidotimod to treat atopic dermatitis

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 12818423

Country of ref document: EP

Kind code of ref document: A2

REEP Request for entry into the european phase

Ref document number: 2012818423

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2012818423

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: DE